SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-070950
Filing Date
2023-12-18
Accepted
2023-12-18 09:34:03
Documents
7
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_2024reversesplits.htm DEF 14A 333745
2 GRAPHIC img195048117_0.jpg GRAPHIC 12897
3 GRAPHIC img195048117_1.jpg GRAPHIC 5049
4 GRAPHIC img195048117_2.jpg GRAPHIC 6824
5 GRAPHIC img195048117_3.jpg GRAPHIC 5183
6 GRAPHIC img195048117_4.jpg GRAPHIC 433914
7 GRAPHIC img195048117_5.jpg GRAPHIC 172201
  Complete submission text file 0000950170-23-070950.txt   1211103
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39871 | Film No.: 231492444
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)